Antiverse Ltd

  • Active
  • Small
  • 8 years
  • 13 employees
  • £2,083,714 (cur assets)
  • 1m-15m
  • Regular importer
  • Real address
  • 7 directors
  • No owners
  • Cardiff

Field of Operation

Research and experimental development on biotechnology
72110 6234 companies

Website

Social media

Summary

Antiverse Ltd, based in Cardiff, UK, is a small, active company founded eight years ago in 2017. It employs eight people and holds £435,124 in assets. With seven directors and no owners reported, the company operates from a real address and regularly imports miscellaneous chemical products—the last import was recorded in February 9 2025. The company’s primary focus is research and experimental development within the biotechnology industry.

The company's website highlights its specialization in antibody design for challenging targets, leveraging generative AI. It emphasizes a partnership with Nxera Pharma and offers services including antibody discovery, design, and optimization. The site also features a team of experts with diverse backgrounds in antibody development, machine learning, and biotechnology. The site is well-designed and clearly communicates Antiverse’s value proposition.

Financially, Antiverse Ltd shows some concerning trends. Current assets have significantly decreased by 77% to £440,000, while net assets have fallen 90% to -£2.3 million. Bank borrowings have increased substantially, reaching £33,000, and cash reserves have plummeted 98% to a mere £30,000. Creditors have also increased, reaching £2.8 million. The company’s small size (meeting two of three criteria for a small company) allows for agility, but the sharp decline in equity suggests a need for additional funding. The number of employees has increased by 62%, to thirteen, which could be a sign of growth or increased operational costs. With no auditor mentioned, the figures rely on unaudited statements.

In short, Antiverse Ltd is facing financial pressures despite its innovative technology and partnerships. The company's focus on AI-driven antibody design shows promise, but sustaining growth will depend on securing additional investment and managing its expenses effectively.

Registered in England/Wales under the registration number 10736975, with a registered address at CF24 4HQ, United Kingdom, Cardiff, Sbarc, Spark 5th Floor, Maindy Rd.

WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.

Managers

  • 7 months
  • 1
Founding partner in i&i bio
  • 1 year
  • 4
Venture capitalist
Venture capital
  • 3 years
  • 1
Senior advisor
  • 5 years
  • 6
Venture creation

Last reports

Download the last financial report
Download the last confirmation report
* may contain a full shareholder list

Last news

  1. Resolutions
  2. Director's details changed for Mr Murat Tunaboylu on 2025-10-06
  3. Registered office address changed from Sbarc, Spark 5th Floor Maindy Rd Cardiff CG24 4HQ United Kingdom to Sbarc, Spark 5th Floor Maindy Rd Cardiff CF24 4HQ on 2025-11-18

Importer profile by HS codes

Click on the map to see detailed UK statistics on HS code, including companies list.

Import HS codes in detail

Last imported products

Click on items to see detailed UK statistics on HS code, including companies list.

* Warning: Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.

FAQ about Antiverse Ltd

Looking for leads in the UK?

Book a demo—see how CorpSignals can help you find UK leads.

Similar companies